Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

SIMPLE SUMMARY: Metastatic pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that has limited treatment options. Standard of care treatment involves systemic chemotherapy, although all tumors invariably develop resistance to these cytotoxic therapies. With the advent of genomic seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Huffman, Brandon M., Ellis, Haley, Jordan, Alexander C., Freed-Pastor, William A., Perez, Kimberly, Rubinson, Douglas A., Sethi, Nilay, Singh, Harshabad, Surana, Rishi, Wolpin, Brian M., Aguirre, Andrew J., Cleary, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776746/
https://www.ncbi.nlm.nih.gov/pubmed/36551707
http://dx.doi.org/10.3390/cancers14246223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776746/
https://www.ncbi.nlm.nih.gov/pubmed/36551707
http://dx.doi.org/10.3390/cancers14246223

Ejemplares similares